Seven Fleet Capital Management LP

13F Portfolio Filings

Most recent 13F: Q2 2026
13D/G filings: 13D on 2 securities, 13G on 2 securities
Location: Mountain View, CA
CIK: 0002092021
All SEC filings: View on sec.gov

Holdings Value

Quarter	Holdings	Value ($000)	Top Holdings	Form Type	Date Filed	Filing ID
Q2 2026	96	605,916	CGON, TNGX, RVMD, PHVS	13F-HR	8/17/2026	000101359426000921
Q1 2026	115	318,257	CG ONCOLOGY INC, TNGX, RVMD, TYRA	RESTATEMENT	6/4/2026	000101359426000652
Q4 2025	85	147,764	CGON, COGT, SLNO, TERN	RESTATEMENT	4/2/2026	000101359426000420

Additional filings from Seven Fleet Capital Management LP that have since been restated

13D and 13G Filings

All 13D and 13G filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each security where the latest filing since 12/18/2024 is a 13D, newest first.

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Veradermics, Inc 13D MANE · 922967104	MANE	922967104	0.2%	80,000	13D	5/5/2026 Event 5/1/2026
Seven Fleet Master Fund LP			0.2%	80,000
Seven Fleet Capital Management LP			0.2%	80,000
Seven Fleet Capital Management GP LLC			0.2%	80,000
Brian Liu			0.2%	80,000
CG Oncology, Inc. 13D/A CGON · 156944100	CGON	156944100	2.0%	1,542,833	13D/A	10/28/2025 Event 10/6/2025
Seven Fleet Master Fund LP			1.9%	1,515,151
Seven Fleet Capital Management LP			1.9%	1,515,151
Seven Fleet Capital Management GP LLC			1.9%	1,515,151
Brian Liu			2.0%	1,542,833

2 other securities where the latest filing is a 13G, the newest filed 8/4/2026. View all